480 related articles for article (PubMed ID: 21048155)
1. Endothelial von Willebrand factor regulates angiogenesis.
Starke RD; Ferraro F; Paschalaki KE; Dryden NH; McKinnon TA; Sutton RE; Payne EM; Haskard DO; Hughes AD; Cutler DF; Laffan MA; Randi AM
Blood; 2011 Jan; 117(3):1071-80. PubMed ID: 21048155
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor regulation of blood vessel formation.
Randi AM; Smith KE; Castaman G
Blood; 2018 Jul; 132(2):132-140. PubMed ID: 29866817
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor and angiogenesis: basic and applied issues.
Randi AM; Laffan MA
J Thromb Haemost; 2017 Jan; 15(1):13-20. PubMed ID: 27778439
[TBL] [Abstract][Full Text] [Related]
4. Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
Groeneveld DJ; Sanders YV; Adelmeijer J; Mauser-Bunschoten EP; van der Bom JG; Cnossen MH; Fijnvandraat K; Laros-van Gorkom BAP; Meijer K; Lisman T; Eikenboom J; Leebeek FWG
Thromb Haemost; 2018 Jan; 118(1):152-160. PubMed ID: 29304535
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia.
Randi AM
Thromb Res; 2016 May; 141 Suppl 2():S55-8. PubMed ID: 27207426
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.
Groeneveld DJ; van Bekkum T; Dirven RJ; Wang JW; Voorberg J; Reitsma PH; Eikenboom J
J Thromb Haemost; 2015 Oct; 13(10):1854-66. PubMed ID: 26270243
[TBL] [Abstract][Full Text] [Related]
7. Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.
Selvam SN; Casey LJ; Bowman ML; Hawke LG; Longmore AJ; Mewburn J; Ormiston ML; Archer SL; Maurice DH; James P
Blood Coagul Fibrinolysis; 2017 Oct; 28(7):521-533. PubMed ID: 28362648
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor, angiodysplasia and angiogenesis.
Randi AM; Laffan MA; Starke RD
Mediterr J Hematol Infect Dis; 2013 Sep; 5(1):e2013060. PubMed ID: 24106610
[TBL] [Abstract][Full Text] [Related]
9. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
10. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
[TBL] [Abstract][Full Text] [Related]
11. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
[TBL] [Abstract][Full Text] [Related]
12. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
Meinkoth JH; Meyers KM
Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.
Starke RD; Paschalaki KE; Dyer CE; Harrison-Lavoie KJ; Cutler JA; McKinnon TA; Millar CM; Cutler DF; Laffan MA; Randi AM
Blood; 2013 Apr; 121(14):2773-84. PubMed ID: 23355534
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand disease and von Willebrand factor.
Sadler B; Castaman G; O'Donnell JS
Haemophilia; 2022 May; 28 Suppl 4(Suppl 4):11-17. PubMed ID: 35521725
[TBL] [Abstract][Full Text] [Related]
15. Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.
Selvam S; James P
Semin Thromb Hemost; 2017 Sep; 43(6):572-580. PubMed ID: 28476066
[TBL] [Abstract][Full Text] [Related]
16. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.
Ewenstein BM; Inbal A; Pober JS; Handin RI
Blood; 1990 Apr; 75(7):1466-72. PubMed ID: 2317558
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand disease mutation spectrum and associated mutation mechanisms.
de Jong A; Eikenboom J
Thromb Res; 2017 Nov; 159():65-75. PubMed ID: 28987708
[TBL] [Abstract][Full Text] [Related]
18. [von Willebrand factor and von Willebrand disease].
Matsui T; Hamako J
Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
[TBL] [Abstract][Full Text] [Related]
19. Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.
Cossutta M; Darche M; Carpentier G; Houppe C; Ponzo M; Raineri F; Vallée B; Gilles ME; Villain D; Picard E; Casari C; Denis C; Paques M; Courty J; Cascone I
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1843-1858. PubMed ID: 31315435
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.
Allerkamp H; Lehner S; Ekhlasi-Hundrieser M; Detering C; Pfarrer C; Depka Prondzinski MV
Comp Med; 2019 Oct; 69(5):401-412. PubMed ID: 31526432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
